Brief: Automodular Corp Agrees To A Business Combination With HLS Therapeutics
Dec 21 (Reuters) - Automodular Corp AMh.V :
* ORATION AGREES TO A BUSINESS COMBINATION WITH HLS
THERAPEUTICS
INC.
* SAYS PURSUANT TO ARRANGEMENT, HLS AND AMD WILL AMALGAMATE
TO
FORM A NEW ENTITY NAMED "HLS THERAPEUTICS INC." ("AMALCO")
* BOARD OF AMD AND HLS HAVE UNANIMOUSLY RECOMMENDED ITS
RESPECTIVE SHAREHOLDERS VOTE IN FAVOUR OF APPROVING ARRANGEMENT
Source text for Eikon: ID:nCCNYD7Lca
Further company coverage: AMh.V
( Bangalore.newsroom@thomsonreuters.com )
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease